C Abildgaard
Overview
Explore the profile of C Abildgaard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
58
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lusher J, Abildgaard C, Arkin S, Mannucci P, Zimmermann R, Schwartz L, et al.
J Thromb Haemost
. 2004 Apr;
2(4):574-83.
PMID: 15102011
Background: Development of recombinant factor VIII (rFVIII) replacement therapy represents a milestone in the treatment of hemophilia A. Objective: The objective of this long-term, multicenter study was to assess the...
2.
Powell J, Bush M, Harrison J, Abildgaard C, Vosburgh E, Thompson A, et al.
Haemophilia
. 2000 May;
6(3):140-9.
PMID: 10792471
Plasma-derived factor VIII concentrates remain an important resource for haemophilia A patients. To improve the safety of these preparations, various methods of viral removal and inactivation have been used that...
3.
Addiego J, Kasper C, Abildgaard C, HILGARTNER M, Lusher J, Glader B, et al.
Lancet
. 1993 Aug;
342(8869):462-4.
PMID: 8102429
Clinical studies evaluating highly purified monoclonal-antibody-derived and recombinant-DNA-derived clotting factor concentrates in previously untreated (PUPS) severe factor VIII (FVIII) deficient haemophilia patients, have documented an increased frequency of inhibitors compared...
4.
Herring S, Abildgaard C, Shitanishi K, Harrison J, Gendler S, Heldebrant C
J Lab Clin Med
. 1993 Mar;
121(3):394-405.
PMID: 8445288
Thromboembolic complications associated with prothrombin complex concentrate treatment may be related to the high levels of factors II and X in these products. We report here results from preclinical safety...
5.
Asakura A, Harrison J, Gomperts E, Abildgaard C
Blood
. 1987 May;
69(5):1419-20.
PMID: 3105622
Type IIA von Willebrand's Disease (vWD) is the most common type II variant, and all reported cases (56 individuals in 26 families) have had autosomal dominant inheritance. An eight-year-old female...
6.
Harrison J, Abildgaard C, LAZERSON J, Culbertson R, Anderson G
Thromb Res
. 1985 Apr;
38(2):173-88.
PMID: 4002204
Infusion of prothrombin complex concentrates into pigs resulted in evidence of disseminated intravascular coagulation manifested by positive fibrin monomer tests, depletion of coagulation factors and platelets, and the presence of...
7.
Rajani K, Goetzman B, Wennberg R, Turner E, Abildgaard C
Pediatrics
. 1979 Apr;
63(4):552-6.
PMID: 375178
Heparinization of fluids (1 unit/ml) infused through an umbilical artery catheter (UAC) was efficacious in prolonging catheter patency in a double-blind, randomized, controlled clinical study. On the basis of life-table...
8.
Spangler W, Gribble D, Abildgaard C, Harrison J
Vet Pathol
. 1978 Jan;
15(1):83-91.
PMID: 415405
Twelve Rhesus monkeys were inoculated intravenously with about 500 000 malaria parasites, Plasmodium knowlesi. Acute hemolysis occurred 5 days later, and all animals died on the 6th or 7th day...
9.
Abildgaard C, Harrison J, DeNardo S, Spangler W, Gribble D
Am J Trop Med Hyg
. 1975 Sep;
24(5):764-8.
PMID: 811125
Uniformly fatal simian malaria was induced in ten rhesus monkeys by injection of Plasmodium knowlesi. The results of serial studies of platelet and blood coagulation factor levels suggested the occurrence...
10.
Abildgaard C, Harrison J, ESPANA C, Spangler W, Gribble D
Am J Trop Med Hyg
. 1975 May;
24(3):537-44.
PMID: 1098497
Simian hemorrhagic fever (SHF) was induced in three species of monkeys (Macaca mulatta, M. radiata and M. fascicularis) using plasma from animals that died with SHF in the 1967 outbreak...